Close

ICON Recognised as Clinical Research Company of the year

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

– Leave Message for Us to Get Back

Related stories

US Health Systems Accelerating AI Collaborations

US Health systems are speeding up their collaborations with...

Senate Draft Cuts to Medicaid and CHIP Criticized

The American Medical Association has spoken out against the...

Alterations In US Healthcare System Likely in Trump 2.0

Apparently, there is one of the analysts who has...

China’s AI Doctors Revolutionize Healthcare with First AI Hospital

China recently announced a ground-breaking development: the world's first...
ICON plc, a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries, announced that it has been named “Clinical Research Company of the year” at the annual PharmaTimes awards.

ICON plc, a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries, announced that it has been named “Clinical Research Company of the year” at the annual PharmaTimes awards.

The PharmaTimes awards, which were announced at a ceremony in London on Thursday, 15th January, recognise and reward excellence in pharmaceutical clinical development. In total, ICON had over thirty staff short-listed as finalists across different categories, the highest number from any organisation.

ICON Clinical Research won gold, silver and bronze in both the Clinical Research Team of the Year and Clinical Research Associate of the Year categories. In addition to this recognition, ICON also received a bronze award in the Project Management category.

Alan Morgan, Chief Operating Officer, ICON Clinical Research, commented: We are delighted with our success at the PharmaTimes awards, as it recognises the outstanding contribution that our people have made to the overall success of the organisation.

Latest stories

Related stories

US Health Systems Accelerating AI Collaborations

US Health systems are speeding up their collaborations with...

Senate Draft Cuts to Medicaid and CHIP Criticized

The American Medical Association has spoken out against the...

Alterations In US Healthcare System Likely in Trump 2.0

Apparently, there is one of the analysts who has...

China’s AI Doctors Revolutionize Healthcare with First AI Hospital

China recently announced a ground-breaking development: the world's first...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

– Leave Message for Us to Get Back